| type : |
Artikel |
| internetlink : |
https://pubmed.ncbi.nlm.nih.gov/18032138/ |
|
| onderzoeksgroepen : |
Nutley - Roche Laboratories |
| Auteur : |
Winiarski AP, Infeld MH, Tscherne R, Bachinsky M, Rucki R, Nagano-Mate K. |
| titel : |
Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules. |
| Nummer : |
J Am Pharm Assoc ; 47, 6; 747-755. 2007 |
|
| Niveau van bewijs : |
|
| fysische stabiliteit : |
|
| chemische stabiliteit : |
|
| andere methoden : |
|
| Reacties : |
|
Stoffenlijst
 Oseltamivir
|
 |
 |
 |
 |
450 mg
Tamiflu® |
|
23-27°C |
 |
| 5 |
 |
|
|
|
|
|
450 mg
Tamiflu® |
|
28-32°C |
|
| 13 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
3-7°C |
|
| 35 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
3-7°C |
|
| 35 |
|
|
|
|
 |
|
450 mg
Tamiflu® |
|
23-27°C |
|
| 5 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
28-32°C |
|
| 13 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
3-7°C |
|
| 35 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
3-7°C |
|
| 35 |
|
|
|
|
|
